| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.00087 | 1 |